A preliminary study to determine the efficacy of using energy specific far infrared (FIR) radiation for the treatment of uterine fibroids.
Uterine fibroids are the most common neoplasms of the female pelvis. These benign tumors are generally oval in shape and often highly vascular. On MR imaging exams, uterine fibroids are easily identifiable. They occur in 20-25% of women of reproductive age and can cause a variety of problems generally described as either bleeding or mass effects from the fibroid. We are postulating that energy specific electromagnetic radiation of the uterus will shrink the benign tumors.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
2
Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes during each session.
The Centre for Incurable Diseases
Toronto, Ontario, Canada
The primary end point is to determine the therapeutic effects of far infrared radiation on uterine fibroids
Time frame: 2 years and 9 months
The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other related uterine conditions, for example, bleeding.
Time frame: Two years and nine months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.